Pacgen Life Science Corporation — Proxy Solicitation & Information Statement 2020

Aug 20, 2020

------Fold

PACGEN LIFE SCIENCE CORPORATION

==> picture [106 x 59] intentionally omitted <==

Security Class

Holder Account Number

Form of Proxy - Annual General and Special Meeting to be held on September 15, 2020

This Form of Proxy is solicited by and on behalf of Management.

Notes to proxy

1. Every holder has the right to appoint some other person or company of their choice, who need not be a holder, to attend and act on their behalf at the meeting or any adjournment or postponement thereof. If you wish to appoint a person or company other than the persons whose names are printed herein, please insert the name of your chosen proxyholder in the space provided (see reverse).

2. If the securities are registered in the name of more than one owner (for example, joint ownership, trustees, executors, etc.), then all those registered should sign this proxy. If you are voting on behalf of a corporation or another individual you must sign this proxy with signing capacity stated, and you may be required to provide documentation evidencing your power to sign this proxy.

3. This proxy should be signed in the exact manner as the name(s) appear(s) on the proxy.

4. If this proxy is not dated, it will be deemed to bear the date on which it is mailed by Management to the holder.

5. The securities represented by this proxy will be voted as directed by the holder, however, if such a direction is not made in respect of any matter, this proxy will be voted as recommended by Management.

6. The securities represented by this proxy will be voted in favour or withheld from voting or voted against each of the matters described herein, as applicable, in accordance with the instructions of the holder, on any ballot that may be called for and, if the holder has specified a choice with respect to any matter to be acted on, the securities will be voted accordingly.

7. This proxy confers discretionary authority in respect of amendments or variations to matters identified in the Notice of Meeting or other matters that may properly come before the meeting or any adjournment or postponement thereof.

8. This proxy should be read in conjunction with the accompanying documentation provided by Management.

------Fold

Proxies submitted must be received by 9:00 a.m. (Pacific Daylight Time) on September 11, 2020

VOTE USING THE TELEPHONE OR INTERNET 24 HOURS A DAY 7 DAYS A WEEK!

==> picture [180 x 38] intentionally omitted <==

----- Start of picture text -----

To Vote Using the Telephone
----- End of picture text -----

==> picture [179 x 38] intentionally omitted <==

----- Start of picture text -----

To Vote Using the Internet
----- End of picture text -----

==> picture [43 x 44] intentionally omitted <==

• Call the number listed BELOW from a touch tone telephone.

• Go to the following web site: www.investorvote.com

• Smartphone?

• 1-866-732-VOTE (8683) Toll Free Scan the QR code to vote now.

If you vote by telephone or the Internet, DO NOT mail back this proxy.

Voting by mail may be the only method for securities held in the name of a corporation or securities being voted on behalf of another individual.

Voting by mail or by Internet are the only methods by which a holder may appoint a person as proxyholder other than the Management nominees named on the reverse of this proxy. Instead of mailing this proxy, you may choose one of the two voting methods outlined above to vote this proxy.

To vote by telephone or the Internet, you will need to provide your CONTROL NUMBER listed below.

CONTROL NUMBER

==> picture [15 x 15] intentionally omitted <==

==> picture [15 x 15] intentionally omitted <==

Appointment of Proxyholder

I/We being holder(s) of Pacgen Life Science Corporation hereby appoint: OR Print the name of the person you are Christina Yip, or failing her, Andrea Chan appointing if this person is someone other than Ms. Yip or Ms. Chan.

==> picture [148 x 30] intentionally omitted <==

as my/our proxyholder with full power of substitution and to attend, act and to vote for and on behalf of the shareholder in accordance with the following direction (or if no directions have been given, as the proxyholder sees fit) and all other matters that may properly come before the Annual General and Special Meeting of the shareholders of Pacgen Life Science Corporation to be held via live audio webcast online at https://zoom.us/j/99895257835?pwd=K2xpSEVQbElRd2M4NmdxOGFwNnR4dz09 (Meeting ID: 998 9525 7835, Passcode: 671114 at 9:00 a.m. (Pacific Time) on September 15, 2020 and at any adjournment or postponement thereof.

VOTING RECOMMENDATIONS ARE INDICATED BY HIGHLIGHTED TEXT OVER THE BOXES.

==> picture [557 x 8] intentionally omitted <==

1.Election of Directors	For	Withhold	For	Withhold	For	Withhold
01. Chung-Yu Wang		02. Christina Yip		03. Rakesh Kumar Arya
							-------
							Fold
04. John Hsuan		05. Fred Huang		06. Telvin Ju
07. Alan Savage
					For	Withhold
2.Appointment of Auditors
Appointment of D&H Group LLP, Chartered Professional Accountants as Auditors of the Company for the ensuing year and authorizing the
Directors to fix their remuneration.
3.Re-Approval of 10% Rolling Stock Option Plan					For	Against
To approve the resolution, the full text	of which is set out in the accompanying management information circular of the Company (the “Circular”), to
re-adopt and re-approve the Company's 2006 Incentive Stock Option Plan, as amended on September 2, 2009 and August 2, 2012, and authorize
the Company to grant stock options pursuant to such plan, such that the aggregate number of common shares of the Company (“Common Shares”)
issuable upon the exercise of outstanding		options at the time of grant shall not exceed 10% of the number of issued and outstanding Common
Shares as at the time of the grant.
					For	Against

4. Approval of Arrangement Resolution

To approve the resolution, the full text of which is set out in Schedule A to the Circular, to approve a plan of arrangement under Section 288 of the Business Corporations Act (British Columbia) pursuant to which General Biologicals Corporation will acquire all of the issued and outstanding Common Shares not owned by General Biologicals Corporation and the Continuing Shareholders (as defined in the Circular).

==> picture [15 x 15] intentionally omitted <==

==> picture [15 x 15] intentionally omitted <==

------Fold

Authorized Signature(s) - This section must be completed for your instructions to be executed.

I/We authorize you to act in accordance with my/our instructions set out above. I/We hereby revoke any proxy previously given with respect to the Meeting. If no voting instructions are indicated above, this Proxy will be voted as recommended by Management.

==> picture [37 x 8] intentionally omitted <==

----- Start of picture text -----

Signature(s)
----- End of picture text -----

==> picture [148 x 29] intentionally omitted <==

Date

==> picture [94 x 20] intentionally omitted <==

Interim Financial Statements - Mark this box if you would Annual Financial Statements - Mark this box if you would like to receive Interim Financial Statements and like to receive the Annual Financial Statements and accompanying Management’s Discussion and Analysis by accompanying Management’s Discussion and Analysis by mail. mail.

==> picture [15 x 15] intentionally omitted <==

If you are not mailing back your proxy, you may register online to receive the above financial report(s) by mail at www.computershare.com/mailinglist.

==> picture [15 x 15] intentionally omitted <==

==> picture [15 x 15] intentionally omitted <==

J P B Q

3 1 3 4 6 6

A R 1